Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 3.
FIG. 3.

Naringenin- and insulin-mediated phosphorylation of ERK1/2 is abolished by MEK1/2 inhibition and potentiated by MAPKp38 inhibition. HepG2 cells in serum-free media were preincubated (30 min) ± UO126 (10 μmol/l) or UO124 (10 μmol/l) (A), or ± SB203580 (10 μmol/l) or SB202474 (10 μmol/l) (B), followed by a 30-min incubation ± naringenin (100 μmol/l) or insulin (100 nmol/l). Total and phosphorylated ERK1/2 (Phos-ERK1/2) were determined by immunoblotting, and the ratio of the phosphorylated form to total ERK1/2 is presented (relative to control) as means ± SE for at least three experiments. *P < 0.05, **P < 0.01 compared with control; †P < 0.05, ‡P < 0.01 compared with naringenin or insulin.

This Article

  1. Diabetes vol. 54 no. 6 1676-1683